School of Medicine
Showing 1,101-1,110 of 1,583 Results
-
Mattias Rydberg
Postdoctoral Scholar, Plastic and Reconstructive Surgery
BioMattias Rydberg, MD, PhD, is a hand surgeon and postdoctoral scholar in the Division of Plastic and Reconstructive Surgery at Stanford University School of Medicine. His research focuses on epidemiology, machine learning, and digital health technologies in hand surgery and musculoskeletal disease. Dr. Rydberg completed his medical and doctoral training at Lund University in Sweden, where his PhD work focused on diabetic hand disorders and large-scale register-based research.
At Stanford, he works in the laboratory of Dr. Paige Fox, studying peripheral nerve disorders, fibroproliferative diseases, and AI-based motion tracking technologies for upper extremity assessment. His current projects include national database studies on diabetes and entrapment neuropathies, frozen shoulder and Dupuytren’s disease, and the development of camera-based hand motion analysis tools using machine learning and computer vision. -
Amin Sadeghi
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsApplications of artificial intelligence in medicine
-
Neetu Saini
Postdoctoral Scholar, Stem Cell Transplantation
BioMy research interests focus on translational human T-cell immunology, with an emphasis on regulatory T cells (Tregs) and their therapeutic potential in restoring immune tolerance and tissue homeostasis. I am particularly interested in engineering FOXP3-programmed CD4⁺ T cells as a stable and functional alternative to conventional Tregs, especially in inflammatory settings where endogenous Tregs may be unstable or dysfunctional. My work integrates gene-editing approaches, immunophenotyping, and human organoid systems to study how these engineered cells interact with epithelial and stem cell compartments, with a focus on mechanisms of tissue repair and immune–epithelial crosstalk in barrier tissues such as the intestine. Moving forward, I aim to advance next-generation cell therapies by combining insights from T-cell biology, tissue biology, and disease modeling to develop durable and clinically relevant strategies for treating immune-mediated and epithelial barrier disorders.
